Funding name
Exploración Molecular de Biomarcadores de Deterioro Cognitivo Asociado a Terapia Adyuvante por Cáncer de Mama
Acronym
102-2018
Funding code
102-2018
Parent funding
Expected Amount
349094
Peruvian Soles
Executed amount
332034
Peruvian Soles
Start Date
18 December 2018
End Date
18 December 2021